PLA2G4A and cystic fibrosis: Both SERPINB4 and CTSC are up-regulated in IL13 treated human primary bronchial epithelial cells on air liquid interface culture [16], and PLA2G4A is more active in bronchial explants from individuals with cystic fibrosis [40].